MiR-140 targets lncRNA FAM230B to suppress cell proliferation in acute myeloid leukemia running title: MiR-140 targets FAM230B in AML
- Resource Type
- article
- Authors
- Yan Wang; Fangfang Wang; Yang Lu; Yan Li; Haonan Ran; Feihu Yan; Yuyang Tian
- Source
- Hematology, Vol 27, Iss 1, Pp 700-705 (2022)
- Subject
- Acute myeloid leukemia
bone marrow mononuclear cells
FAM230B
miR-140
Diseases of the blood and blood-forming organs
RC633-647.5
- Language
- English
- ISSN
- 16078454
1607-8454
Background FAM230B serves as an oncogenic lncRNA in both gastric cancer and papillary thyroid cancer, while its role in acute myeloid leukemia (AML) is unclear. We predicted that FAM230B could be a target of miR-140, a well-characterized tumor suppressor, and analyzed their interaction in AML.Methods Differential expressions of FAM230B and miR-140 in bone marrow mononuclear cells (BMMNCs) were determined by RT-qPCR. Correlations were analyzed by Pearson’s correlation coefficient. Subcellular FAM230B location was determined using cellular fractionation assay. The direct interaction between FAM230B and miR-140 was confirmed by RNA pull-down assay. The roles of FAM230B and miR-140 in cell proliferation were explored using BrdU assay.Results High FAM230B expression level and low miR-140 expression level were observed in AML. FAM230B and miR-140 were inversely correlated and directly interacted with each other. FAM230B could be detected in both cytoplasm and nuclear samples. MiR-140 overexpression downregulated FAM230B expression and suppressed the enhancing effects of FAM230B overexpression on cell proliferation.Conclusion MiR-140 may target FAM230B to suppress cell proliferation in AML.